T0	Participants 25 65	randomized multicenter study SAKK 40/81:
T1	Participants 98 136	curatively resected colorectal cancer]
T2	Participants 139 234	Between 1981 and 1987, 533 patients from 9 institutions have been entered in a randomized trial
T3	Participants 360 499	469 evaluable patients at a median follow-up of 5.8 years revealed 110 recurrences in the control and 94 recurrences in the infusion group.